Refine
Document Type
- Article (11)
- Report (7)
- Conference Proceeding (4)
- Working Paper (2)
- Book (1)
- Part of a Book (1)
- Other (1)
Institute
- Forschungszentrum Business Informatics (27) (remove)
Has Fulltext
- yes (27) (remove)
Is part of the Bibliography
- yes (27)
Keywords
- Global optimization (3)
- Rastrigin function (3)
- Evolution Strategies (2)
- Evolution strategy (2)
- Progress rate (2)
- Alternative routing (1)
- Anaesthetics (1)
- Anonymizing recorded tracks (1)
- D/H isotopic exchange (1)
- Data Sharing (1)
A model is presented that allows for the calculation of the success probability by which a vanilla Evolution Strategy converges to the global optimizer of the Rastrigin test function. As a result a population size scaling formula will be derived that allows for an estimation of the population size needed to ensure a high convergence security depending on the search space dimensionality.
Adult muscle carnitine palmitoyltransferase (CPT) II deficiency is a rare autosomal recessive disorder of long-chain fatty acid metabolism. It is typically associated with recurrent episodes of exercise-induced rhabdomyolysis and myoglobinuria, in most cases caused by a c.338C > T mutation in the CPT2 gene. Here we present the pedigree of one of the largest family studies of CPT II deficiency caused by the c.338C > T mutation, documented so far. The pedigree comprises 24 blood relatives
of the index patient, a 32 year old female with genetically proven CPT II deficiency. In total, the mutation was detected in 20 family members, among them five homozygotes and 15 heterozygotes. Among all homozygotes, first symptoms of CPT II deficiency occurred during childhood. Additionally, two already deceased relatives of the index patient were carriers of at least one copy of the genetic variant, revealing a remarkably high prevalence of the c.338C > T mutation within the tested family. Beside the index patient, only one individual had been diagnosed with CPT II deficiency prior to this study and three cases of CPT II deficiency were newly detected by this family study, pointing
to a general underdiagnosis of the disease. Therefore, this study emphasizes the need to raise awareness of CPT II deficiency for correct diagnosis and accurate management of the disease.
ÖMG Conference 2019
(2019)